Paris Descartes University, Faculty of Medicine; AP-HP; Diagnosis and Therapeutics Centre, Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu Hospital, Paris, France.
State University of New York Upstate Medical University, Syracuse, New York, USA.
Am J Hypertens. 2017 Oct 1;30(10):947-953. doi: 10.1093/ajh/hpx049.
In recent years, the predictive value of 2 pulsatile parameters has been extensively studied in hypertension: aortic stiffness and pulse pressure (PP) amplification. Aortic stiffness is an index of aortic rigidity and PP-amplification is the ratio between central and brachial PP, an indirect evaluation of wave reflections. Both are safe, independent, noninvasive predictors of overall and cardiovascular risk. Our purpose is to determine the validity of these parameters in 2 different circumstances: gender and therapeutic implications.
Studies have shown that whereas steady mean arterial pressure is significantly higher in men than in women, pulsatile pressure largely predominates in women, mostly in older age and as a consequence of short stature. Gender differences require more extensive investigation due to the disparities of dose-response ranging among populations and the contribution of ethnic factors, frequently based on individual origin.
Many questions have yet to be resolved. First, the prognosis of antihypertensive therapy is largely based on blood pressure reduction but also requires evaluation of arterial rigidity and wave reflections to achieve adequate therapeutic "de-stiffening." The most effective approach appears to be the combination of angiotensin- and calcium-channel blockade, in certain cases associated with diuretic compounds. Second, antialdosterone drugs can be useful, but it is their antifibrotic more than their antihypertensive effect that appears effective. Third, prevention of comorbidities, such as those associating hypertension, diabetes, and/or kidney damage, should become primary targets for drug treatment.
近年来,在高血压领域,已经广泛研究了 2 个脉动参数的预测价值:主动脉僵硬和脉搏压(PP)放大。主动脉僵硬是主动脉刚性的指标,而 PP 放大是中心和肱动脉 PP 之间的比值,是波反射的间接评估。两者都是安全、独立、无创的整体和心血管风险预测指标。我们的目的是确定这些参数在 2 种不同情况下的有效性:性别和治疗意义。
研究表明,虽然男性的稳定平均动脉压明显高于女性,但脉动压在女性中占主导地位,主要是在老年和身材矮小的情况下。由于剂量反应在人群中的差异以及种族因素的影响,性别差异需要更广泛的研究,这些因素通常基于个体起源。
仍有许多问题尚未解决。首先,抗高血压治疗的预后在很大程度上取决于血压降低,但还需要评估动脉僵硬和波反射,以实现足够的治疗“减硬”。最有效的方法似乎是血管紧张素和钙通道阻滞剂的联合应用,在某些情况下与利尿剂化合物联合应用。其次,醛固酮拮抗剂可能有用,但它们的抗纤维化作用似乎比降压作用更有效。第三,预防高血压、糖尿病和/或肾脏损害等合并症应成为药物治疗的主要目标。